Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
114.29%
0%
114.29%
6 Months
223.08%
0%
223.08%
1 Year
165.82%
0%
165.82%
2 Years
144.19%
0%
144.19%
3 Years
59.09%
0%
59.09%
4 Years
17.32%
0%
17.32%
5 Years
25.0%
0%
25.0%
Biosino Bio-Technology & Science, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.46%
EBIT Growth (5y)
-1.58%
EBIT to Interest (avg)
9.76
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
0.50
Sales to Capital Employed (avg)
1.00
Tax Ratio
24.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.80%
ROE (avg)
4.41%
Valuation key factors
Factor
Value
P/E Ratio
3
Industry P/E
Price to Book Value
0.37
EV to EBIT
7.32
EV to EBITDA
4.00
EV to Capital Employed
0.58
EV to Sales
0.41
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
7.92%
ROE (Latest)
10.71%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'16 - YoY
Dec'16
Dec'15
Change(%)
Net Sales
88.20
96.80
-8.88%
Operating Profit (PBDIT) excl Other Income
13.00
-7.90
264.56%
Interest
1.50
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
11.50
-4.70
344.68%
Operating Profit Margin (Excl OI)
74.80%
-81.10%
15.59%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2016 is -8.88% vs 10.63% in Dec 2015
Consolidated Net Profit
YoY Growth in quarter ended Dec 2016 is 344.68% vs -173.44% in Dec 2015
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
285.20
319.40
-10.71%
Operating Profit (PBDIT) excl Other Income
-22.80
0.10
-22,900.00%
Interest
10.10
7.10
42.25%
Exceptional Items
-14.10
-0.70
-1,914.29%
Consolidate Net Profit
-61.70
-21.30
-189.67%
Operating Profit Margin (Excl OI)
-145.00%
-67.60%
-7.74%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -10.71% vs -26.37% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -189.67% vs -229.09% in Dec 2023
About Biosino Bio-Technology & Science, Inc. 
Biosino Bio-Technology & Science, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






